Pulmonary Lung Diseases Stem Cell Therapy
HEALTHY LUNG WITHOUT DISEASES
LUNG CANCER NEED STEM CELLS
Benefits for Pulmonary Lung Diseases Stem Cell Therapy
Lung tissue regeneration:
Mesenchymal stem cells have the ability to differentiate into various cell types, including lung cells, which may contribute to the repair and regeneration of damaged lung tissue in respiratory diseases such as cystic fibrosis.
Anti-inflammatory and immune modulating action:
The Mesenchymal stem cells can suppress excessive inflammatory response in the lungs, which is beneficial in chronic respiratory diseases such as cystic fibrosis and in the sequelae of COVID-19, where inflammation plays an important role.
Antioxidant effects:
Studies have shown that Mesenchymal stem cells can reduce oxidative stress in lung tissues , which helps prevent cell damage and promote healing in respiratory diseases.
Improved lung function:
Mesenchymal stem cells therapy has been shown to improve lung function in patients with chronic respiratory diseases, which may be especially relevant in cases of cystic fibrosis and sequelae of COVID-19, where lung function may be compromised.
Reduction of fibrosis:
Mesenchymal stem cells can inhibit the formation of excessive scar tissue in the lungs, which is especially important in diseases such as cystic fibrosis, where progressive fibrosis is a major feature.
Symptom relief in "long COVID":
In patients with sequelae of COVID-19, mesenchymal stem cell therapy can help relieve persistent symptoms such as fatigue, shortness of breath and chest pain, thus improving patients' quality of life.
*including cystic fibrosis and sequelae of COVID-19
These benefits are based on recent scientific evidence and support the therapeutic potential of mesenchymal stem cells in the treatment of respiratory diseases, including cystic fibrosis and the sequelae of COVID-19.
Basic Info Lung Diseases Stem Cell Therapy
A blood sample from the patient is required at least 3 hours before the procedure to sensitize the MSC’s with the patient’s serum. Preferably take a blood sample 1 day before. When the patient is local and only has treatment with MSC’s, it may be easier to schedule the patient to come for sampling one day prior to their MSC’s treatment.
*Important; patients must pay in full 5 days prior to their scheduled treatment date to ensure fresh mesenchymal stem cells.
None of the patients have had any side effects as a result of the administration of mesenchymal stem cells.